Levosalbutamol cream - Cipher Pharmaceuticals
Alternative Names: R-salbutamol cream - Astion Pharma; ASF-1096Latest Information Update: 02 Oct 2021
At a glance
- Originator Astion Pharma A/S
- Developer Astion Pharma A/S; Edesa Biotech
- Class Antiasthmatics; Benzene derivatives; Bronchodilators; Ethanolamines; Phenethylamines; Skin disorder therapies; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Cutaneous lupus erythematosus; Discoid lupus erythematosus
- No development reported Gastrointestinal disorders
Most Recent Events
- 28 Aug 2021 No recent reports of development identified for preclinical development in Gastrointestinal-disorders in Canada
- 09 Aug 2019 Levosalbutamol cream is still in phase III trial for Cutaneous lupus erythematosus in Denmark and Spain (Topical) (EudraCT2007-004635-29)
- 09 Aug 2019 Levosalbutamol cream is still in phase III trial for Discoid lupus erythematosus in Denmark and Spain (Topical) (EudraCT2007-004635-29)